Real Life Multicenter Comparison of 24-Month Outcomes of Anti-VEGF Therapy in Diabetic Macular Edema in Turkey: Ranibizumab vs. Aflibercept vs. Ranibizumab-Aflibercept Switch

The aim of this study was to compare the outcomes of diabetic macular edema (DME) treated with aflibercept (AFB) or ranibizumab (RNB) only, and after switching from RNB to AFB. This was a retrospective, real-world, multicenter (7 cities) 24 month study. Overall, 212 eyes in the AFB group, 461 in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucukevcilioglu, Murat, Yeşiltaş, Yağmur Seda, Durukan, Ali Hakan, Unlu, Nurten, Onen, Mehmet, Alp, Mehmet Numan, Kalayci, Defne, Acar, Mehmet Akif, Sekeroglu, Mehmet Ali, Citirik, Mehmet, Altintas, Ayse Gul Kocak, Hazirolan, Dicle, Ozdal, Pinar Cakar, Toklu, Yasin, Bicer, Tolga, Ugurlu, Nagihan, Budakoglu, Ozlem, Yazar, Zeliha, Zeki, Nil Irem Ucgun, Serdar, Kurtulus, Doguizi, Sibel, Erol, Yasemin Ozdamar, Atilgan, Cemile Ucgul, Yorgun, Mucella Arikan, Soba, Dilek Ozcelik, Berker, Nilufer, Baskan, Ceyda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964409/
https://www.ncbi.nlm.nih.gov/pubmed/36837465
http://dx.doi.org/10.3390/medicina59020263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964409/
https://www.ncbi.nlm.nih.gov/pubmed/36837465
http://dx.doi.org/10.3390/medicina59020263

Ejemplares similares